NURECA

Nureca Share Price

 

 

Start SIP in NURECA

Start SIP
Nureca live price: ₹267.9. It opened at ₹260 vs previous close ₹260; intraday high/low: ₹270/₹255. The 50 & 200 DMA stand at ₹282.32/₹276.10.

Nureca Performance

  • Low
  • ₹255
  • High
  • ₹270
  • 52 Week Low
  • ₹204
  • 52 Week High
  • ₹343
  • Open Price₹260
  • Previous Close₹260
  • Volume14,647
  • 50 DMA₹282.32
  • 100 DMA₹279.89
  • 200 DMA₹276.10

Investment Returns

  • Over 1 Month -5.35%
  • Over 3 Month -14.44%
  • Over 6 Month + 4.32%
  • Over 1 Year + 16.36%

Smart Investing Starts Here Start SIP with Nureca for Steady Growth!

Invest Now

Nureca Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 25.2
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 268
  • P/B Ratio
  • 1.3
  • Average True Range
  • 13.9
  • EPS
  • 11.15
  • Dividend Yield
  • 0
  • MACD Signal
  • -3.19
  • RSI
  • 42.07
  • MFI
  • 47.83

Nureca Financials

Nureca Technicals

EMA & SMA

Current Price
₹267.90
+ 7.55 (2.9%)
pointer
  • Bearish Moving Average 14
  • Bullish Moving Average 2
  • 20 Day
  • ₹277.81
  • 50 Day
  • ₹282.32
  • 100 Day
  • ₹279.89
  • 200 Day
  • ₹276.10

Resistance and Support

264.3 Pivot Speed
  • R3 288.60
  • R2 279.30
  • R1 273.60
  • S1 258.60
  • S2 249.30
  • S3 243.60

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Nureca has an operating revenue of Rs. 143.30 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 1% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 24% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 67 which is a FAIR score but needs to improve its earnings, a RS Rating of 61 which is FAIR indicating the recent price performance, Buyer Demand at D+ which indicates heavy supply, Group Rank of 85 indicates it belongs to a poor industry group of Medical-Products and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Nureca Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-17 Quarterly Results & Others To consider other business matters. per share(20%)Final Dividend
2025-11-28 Buy Back of Shares
2025-11-10 Buy Back of Shares
2025-10-16 Quarterly Results & Others To consider other business matters. per share(20%)Final Dividend
2025-07-15 Quarterly Results
Date Purpose Remarks
2022-02-25 INTERIM Rs.3.00 per share(30%)Interim Dividend
View Nureca Dividend History Arrow

Nureca F&O

Nureca Shareholding Pattern

68.09%
0%
0%
0.09%
0%
29.73%
2.09%

About Nureca

  • NSE Symbol
  • NURECA
  • BSE Symbol
  • 543264
  • Chairman & Managing Director
  • Mr. Saurabh Goyal
  • ISIN
  • INE0DSF01015

Similar Stocks to Nureca

Nureca FAQs

Nureca share price is ₹267 As on 13 March, 2026 | 04:27

The Market Cap of Nureca is ₹267.9 Cr As on 13 March, 2026 | 04:27

The P/E ratio of Nureca is 25.2 As on 13 March, 2026 | 04:27

The PB ratio of Nureca is 1.3 As on 13 March, 2026 | 04:27

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23